Live Breaking News & Updates on News Ratings For Rocket Pharmaceuticals Daily|Page 5

Stay updated with breaking news from News ratings for rocket pharmaceuticals daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dana Investment Advisors Inc. Trims Holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)

Dana Investment Advisors Inc. decreased its holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 7.9% during the third quarter, HoldingsChannel.com reports. The firm owned 15,409 shares of the biotechnology company’s stock after selling 1,315 shares during the quarter. Dana Investment Advisors Inc.’s holdings in Rocket Pharmaceuticals were worth $316,000 at the end of […] ....

Gaurav Shah , Martin Wilson , Rathbones Group , Securities Exchange Commission , Rocket Pharmaceuticals , Cantor Fitzgerald , Bamco Inc , Financial Services Group Inc , Rocket Pharmaceuticals Inc , Rocket Pharmaceuticals Profile , Dana Investment Advisors Inc , Rocket Pharmaceuticals Stock Performance , York Mellon Corp , Needham Company , News Ratings For Rocket Pharmaceuticals Daily , Charles Schwab Investment Management Inc , Quarter For Rocket Pharmaceuticals , Jpmorgan Chase Co , Dana Investment Advisors , Free Report , Investment Advisors , Schwab Investment Management , New York Mellon Corp , Services Group , Get Free Report , Exchange Commission ,

Cantor Fitzgerald Reiterates "Overweight" Rating for Rocket Pharmaceuticals (NASDAQ:RCKT)

Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report)‘s stock had its “overweight” rating reiterated by investment analysts at Cantor Fitzgerald in a report released on Tuesday, Benzinga reports. They currently have a $65.00 price target on the biotechnology company’s stock. Cantor Fitzgerald’s price target would suggest a potential upside of 123.91% from the stock’s previous close. […] ....

Kinnari Patel , Martin Wilson , Synovus Financial Corp , Rocket Pharmaceuticals , Institutional Trading Of Rocket Pharmaceuticals , Securities Exchange Commission , Rocket Pharmaceuticals Inc , Needham Company , Cantor Fitzgerald , Analyst Recommendations For Rocket Pharmaceuticals , Hightower Advisors , Rocket Pharmaceuticals Stock Down , Metlife Investment Management , Jpmorgan Chase Co , News Ratings For Rocket Pharmaceuticals Daily , Get Free Report , Pharmaceuticals Stock Down , General Counsel Martin Wilson , Exchange Commission , Tower Advisors , Life Investment Management , Financial Corp , Rocket Pharmaceuticals Daily , Nasdaq Rckt , Reiterated Rating ,

Rocket Pharmaceuticals' (RCKT) "Overweight" Rating Reaffirmed at Cantor Fitzgerald

Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report)‘s stock had its “overweight” rating restated by investment analysts at Cantor Fitzgerald in a research note issued to investors on Tuesday, Benzinga reports. They currently have a $65.00 target price on the biotechnology company’s stock. Cantor Fitzgerald’s price objective suggests a potential upside of 118.93% from the stock’s […] ....

Martin Wilson , Kinnari Patel , Rocket Pharmaceuticals Inc , Rocket Pharmaceuticals , Rocket Pharmaceuticals Trading Down , News Ratings For Rocket Pharmaceuticals Daily , Hedge Funds Weigh In On Rocket Pharmaceuticals , Metlife Investment Management , Needham Company , Jpmorgan Chase Co , Cantor Fitzgerald , Insider Transactions At Rocket Pharmaceuticals , Analyst Recommendations For Rocket Pharmaceuticals , Synovus Financial Corp , Hightower Advisors , Get Free Report , Lifesci Capital , Pharmaceuticals Trading Down , General Counsel Martin Wilson , Tower Advisors , Life Investment Management , Financial Corp , Rocket Pharmaceuticals Daily , Nasdaq Rckt , Reiterated Rating ,

JPMorgan Chase & Co. Cuts Rocket Pharmaceuticals (NASDAQ:RCKT) Price Target to $50.00

Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report) had its target price decreased by research analysts at JPMorgan Chase & Co. from $55.00 to $50.00 in a research note issued on Tuesday, Benzinga reports. The firm presently has an “overweight” rating on the biotechnology company’s stock. JPMorgan Chase & Co.‘s price target would suggest a potential […] ....

Gaurav Shah , Martin Wilson , Rocket Pharmaceuticals Stock , Rocket Pharmaceuticals Inc , Jpmorgan Chase Co , News Ratings For Rocket Pharmaceuticals Daily , Wells Fargo Company , Rocket Pharmaceuticals , Needham Company , Advisor Group Holdings Inc , Life Insurance Co , Steward Partners Investment Advisory , Cantor Fitzgerald , China Universal Asset Management Co , Analyst Recommendations For Rocket Pharmaceuticals , Get Free Report , Lifesci Capital , General Counsel Martin Wilson , Group Holdings , Partners Investment Advisory , Universal Asset Management , Rocket Pharmaceuticals Daily , Nasdaq Rckt , Lower Price Target , Jpmorgan Chase Co ,

JPMorgan Chase & Co. Cuts Rocket Pharmaceuticals (NASDAQ:RCKT) Price Target to $50.00

JPMorgan Chase & Co. Cuts Rocket Pharmaceuticals (NASDAQ:RCKT) Price Target to $50.00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Gaurav Shah , Martin Wilson , Rocket Pharmaceuticals Stock , Jpmorgan Chase Co , Rocket Pharmaceuticals Inc , Wells Fargo Company , Life Insurance Co , Cantor Fitzgerald , Steward Partners Investment Advisory , China Universal Asset Management Co , Analyst Recommendations For Rocket Pharmaceuticals , Needham Company , News Ratings For Rocket Pharmaceuticals Daily , Rocket Pharmaceuticals , Advisor Group Holdings Inc , Get Free Report , Lifesci Capital , General Counsel Martin Wilson , Group Holdings , Partners Investment Advisory , Universal Asset Management , Rocket Pharmaceuticals Daily ,